Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 9.3B | 7.5B | 6.2B |
Cost of revenue | 3.6B | 4.5B | 3.7B | 3.0B |
Gross profit | 4.2B | 4.8B | 3.8B | 3.2B |
Operating expense | ||||
Research & development | 1.2B | 1.1B | 1.1B | 1.1B |
Selling general and admin | 280.7M | 318.4M | 297M | 277M |
Other operating expenses | — | — | — | — |
Operating income | 2.7B | 3.4B | 2.4B | 1.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.8B | 3.4B | 2.4B | 1.8B |
Tax provision | 465.1M | 723.8M | 441.2M | 291.6M |
Net income | 2.4B | 2.7B | 2.1B | 1.6B |
Basic EPS | 6 | 6.9 | 5.3 | 4.0 |
Diluted EPS | 6 | 6.8 | 5.3 | 4.0 |
Basic average shares | 344.9M | 345.8M | 345.7M | 345.7M |
Diluted average shares | 345.0M | 346.0M | 346.0M | 345.9M |
EBITDA | 3.0B | 3.8B | 2.7B | 2.1B |
Net income from continuing op. | 2.4B | 2.7B | 2.1B | 1.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |